North America Varicose Veins Treatment Market
North America Varicose Veins Treatment Market Size More Than Doubles to Touch USD 791 Million by 2029
Published | 11 October 2023
North America varicose veins treatment market is gaining traction because of the rising prevalence of varicose veins and technological advancements in varicose veins treatment.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the North America varicose veins treatment market size at USD 376.2 million in 2022. During the forecast period between 2023 and 2029, BlueWeave expects the North America varicose veins treatment market size to grow at a CAGR of 11.2% reaching a value of USD 790.96 million by 2029. The increased incidence of varicose veins, numerous technical developments, and accessibility of cutting-edge therapies are major growth factors for the North American varicose veins treatment market. Additionally, high healthcare spending and a growing older population in the region will influence the growth of the North America varicose veins treatment market.
North America Varicose Veins Treatment Market – Overview
Varicose veins are anomalous, dilated blood vessels brought on by the vessel walls deteriorating. These veins under the skin seemed to be a twisted, bloated cluster of blue or purple veins. Technically, there is no medically accepted treatment for varicose veins. The entire vein is collapsed and blood is diverted to another vein instead of treating a varicose vein. The vein is still present; it is only inactive. In certain cases, the injured vein may be removed by the physicians.
North America Varicose Veins Treatment Market
North America Varicose Veins Treatment Market – By Treatment Mode
Based on treatment mode, the North America varicose veins treatment market is segmented into endovenous ablation, injection sclerotherapy, and surgical ligation/stripping. The surgical ligation/stripping accounts for the highest share in the market. The Hopkins Medicine says that surgical ligation surgeries close and shrinks off the varicose veins. The vein is then sealed off and the blood then travels via neighboring veins in its place. It is a minor surgery which improves blood flow and mitigates symptoms like pain and swellings, which influences its growing demand in the market.
Impact of COVID-19 on the North America Varicose Veins Treatment Market
The COVID-19 pandemic slowed the growth of the North America varicose veins treatment market. The United States and Canada were severely affected by the virus outbreak in their respective countries. Hospitals and other medical facilities were overburdened with COVID-19 cases, reducing the number of in-patient treatment of non-COVID-19 patients to avoid exposing visiting patients to hospital-acquired diseases. The immediate postponement of all unnecessary procedures in order to conserve medical resources led to a delay in varicose vein treatments, which in turn constrained market expansion. However, it is projected that the market will expand after COVID-19 as all the postponed varicose vein operations and treatments resume.
Major players operating in North America varicose veins treatment market include AngioDynamics, Inc., Vascular Solutions, Inc., Sciton, Inc., Merz Aesthetics, Candela Medical, Teleflex Incorporated, Merit Medical Systems, and Boston Scientific Corporation. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the North America Varicose Veins Treatment Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the North America Varicose Veins Treatment Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
BlueWeave Consulting provides comprehensive Market Intelligence (MI) Solutions to businesses regarding various products and services online and offline. We offer all-inclusive market research reports by analyzing qualitative and quantitative data to boost the performance of your business solutions. BlueWeave has built its reputation by delivering quality inputs and nourishing long-lasting relationships with its clients. We are one of the promising digital MI solutions companies providing agile assistance to make your business endeavors successful.
BlueWeave Consulting & Research Pvt Ltd
+1 866 658 6826 | +1 425 320 4776 | +44 1865 60 0662
- North America Varicose Veins Treatment Market, By Products (Ablation Devices, Venous Closure Products, Surgical Products); By Treatment Mode (Endovenous Ablation, Injection Sclerotherapy, Surgical Ligation/Stripping); By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
Publish Date: October 2023
The increasing prevalence of varicose veins and technological advancements in varicose vein treatment are expected to boost the growth of the North America varicose veins treatment market during the forecast period between 2023 and 2029.
Relevant Press Releases
- Europe Prothrombin Complex Concentrate Market to Reach USD 409.5 Million by 2028
- Global Primary Cells Market Size Doubles to Reach USD 8.6 Billion by 2029
- Surgical Robotics Market is Forecast to Grow at a CAGR of 18.4% until 2028
- Vietnam In Vitro Diagnostics (IVD) Market Size Set to Touch USD 1.9 Billion by 2029
- United States Medical Imaging Monitor Market Set to Grow at a CAGR of 8.4%